Blog
What Makes a Genetic Hearing Disorder a Potential Gene-Therapy Target?
A plain-language look at the questions researchers ask before a genetic condition can become a
A plain-language look at the questions researchers ask before a genetic condition can become a
The STRC gene sits beside a nearly identical copy of itself, and that arrangement can
A genetic hearing loss diagnosis can feel isolating. These organizations and online communities offer reliable
A first approved therapy, a new trial for the most common genetic cause of deafness,
Free genetic testing for hearing loss is already available in the United States. Here is
Why two closely located systems can be connected, affected differently, and studied in different ways.
A practical guide to understanding what each approach does, who may be evaluated, and why
Introduction Hearing is one of our most vital senses — it connects us to conversations,
Your child’s STRC hearing loss diagnosis isn’t the end of their story—it’s the beginning of
CEO Jim Ayala Explains Hearing Loss Progression—from early symptoms to deafness. By tracking this progression, RHI aims to create targeted interventions to preserve hearing. Discover key insights from studies, current treatment limitations, and innovative strategies to address hearing loss’s root causes. This research provides hope for patients and lays the groundwork for transformative therapies. Read on to learn more!
PRESS RELEASE • MAY 2026
MED-EL has acquired full rights to Rescue Hearing’s MYO7A and STRC gene therapy programs, expanding research into gene-based therapeutic approaches targeting genetic causes of hearing and balance disorders.